1. Cytokine modulation of type XV collagen gene expression in human dermal fibroblast cultures.
- Author
-
Kivirikko S, Mauviel A, Pihlajaniemi T, and Uitto J
- Subjects
- Cells, Cultured, Gene Expression drug effects, Humans, Interleukin-1 pharmacology, Kinetics, RNA, Messenger genetics, RNA, Messenger metabolism, Skin cytology, Transforming Growth Factor beta administration & dosage, Transforming Growth Factor beta pharmacology, Tumor Necrosis Factor-alpha administration & dosage, Tumor Necrosis Factor-alpha pharmacology, Collagen genetics, Cytokines pharmacology, Fibroblasts drug effects, Fibroblasts metabolism, Skin drug effects, Skin metabolism
- Abstract
The expression of type XV collagen was studied in cultured human dermal fibroblasts exposed to transforming growth factor-beta (TGF-beta), tumor necrosis factor-alpha (TNF-alpha) or interleukin-1beta (IL-1beta), cytokines which have been shown previously to alter the expression of several extracellular matrix genes. TGF-beta enhanced the expression of the type XV collagen gene (COL15A1) in a time-dependent manner, up to 4.3-fold after 24 h of incubation, whereas TNF-alpha and IL-1beta reduced the mRNA steady-state levels by 32 and 80%, respectively. When TGF-beta and TNF-alpha were added together to the cultures, the stimulatory effect of TGF-beta on type XV collagen gene expression was abrogated, indicating antagonistic modulation by these 2 cytokines. These data suggest that the cytokines tested in this study may contribute to the regulation of type XV collagen synthesis in a variety of tissues which have recently been shown to express this particular collagen gene.
- Published
- 1999
- Full Text
- View/download PDF